title: Improving rheumatoid arthritis outcomes: how do we get there?
authors.affiliation: Veterans Affairs Medical Center, College of Pharmacy, University of Tennessee, Memphis, TN, USA. James.Brown12f230@va.gov
authors.forename: J Richard
authors.initials: JR
authors.lastname: Brown
authors.forename: Carlo
authors.initials: C
authors.lastname: Marra
authors.forename: Frank
authors.initials: F
authors.lastname: Pucino
authors.forename: Beth H
authors.initials: BH
authors.lastname: Resman-Targoff
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha